Orthofix Medical (OFIX) Competitors $16.30 +0.16 (+0.99%) (As of 09/19/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends OFIX vs. SIBN, ANIK, XENT, VAPO, IART, ATRC, ATEC, SRDX, ANGO, and ARAYShould you be buying Orthofix Medical stock or one of its competitors? The main competitors of Orthofix Medical include SI-BONE (SIBN), Anika Therapeutics (ANIK), Intersect ENT (XENT), Vapotherm (VAPO), Integra LifeSciences (IART), AtriCure (ATRC), Alphatec (ATEC), Surmodics (SRDX), AngioDynamics (ANGO), and Accuray (ARAY). These companies are all part of the "medical" sector. Orthofix Medical vs. SI-BONE Anika Therapeutics Intersect ENT Vapotherm Integra LifeSciences AtriCure Alphatec Surmodics AngioDynamics Accuray SI-BONE (NASDAQ:SIBN) and Orthofix Medical (NASDAQ:OFIX) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, analyst recommendations, profitability, institutional ownership, dividends, community ranking, media sentiment and valuation. Does the MarketBeat Community believe in SIBN or OFIX? Orthofix Medical received 247 more outperform votes than SI-BONE when rated by MarketBeat users. However, 67.77% of users gave SI-BONE an outperform vote while only 61.80% of users gave Orthofix Medical an outperform vote. CompanyUnderperformOutperformSI-BONEOutperform Votes16467.77% Underperform Votes7832.23% Orthofix MedicalOutperform Votes41161.80% Underperform Votes25438.20% Is SIBN or OFIX more profitable? Orthofix Medical has a net margin of -15.61% compared to SI-BONE's net margin of -27.10%. Orthofix Medical's return on equity of -20.68% beat SI-BONE's return on equity.Company Net Margins Return on Equity Return on Assets SI-BONE-27.10% -24.27% -17.98% Orthofix Medical -15.61%-20.68%-13.32% Do analysts prefer SIBN or OFIX? SI-BONE currently has a consensus target price of $23.00, suggesting a potential upside of 45.29%. Orthofix Medical has a consensus target price of $20.00, suggesting a potential upside of 22.70%. Given SI-BONE's stronger consensus rating and higher probable upside, equities analysts plainly believe SI-BONE is more favorable than Orthofix Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SI-BONE 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00Orthofix Medical 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 Do institutionals and insiders hold more shares of SIBN or OFIX? 98.1% of SI-BONE shares are held by institutional investors. Comparatively, 89.8% of Orthofix Medical shares are held by institutional investors. 5.4% of SI-BONE shares are held by company insiders. Comparatively, 4.7% of Orthofix Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has more volatility and risk, SIBN or OFIX? SI-BONE has a beta of 1.22, suggesting that its stock price is 22% more volatile than the S&P 500. Comparatively, Orthofix Medical has a beta of 1.05, suggesting that its stock price is 5% more volatile than the S&P 500. Which has better valuation & earnings, SIBN or OFIX? SI-BONE has higher earnings, but lower revenue than Orthofix Medical. SI-BONE is trading at a lower price-to-earnings ratio than Orthofix Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSI-BONE$138.89M4.75-$43.34M-$1.09-14.52Orthofix Medical$771.65M0.79-$151.40M-$3.38-4.82 Does the media prefer SIBN or OFIX? In the previous week, Orthofix Medical had 30 more articles in the media than SI-BONE. MarketBeat recorded 32 mentions for Orthofix Medical and 2 mentions for SI-BONE. SI-BONE's average media sentiment score of 1.44 beat Orthofix Medical's score of 0.03 indicating that SI-BONE is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SI-BONE 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Orthofix Medical 1 Very Positive mention(s) 2 Positive mention(s) 29 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummarySI-BONE beats Orthofix Medical on 11 of the 18 factors compared between the two stocks. Ad Investors AlleyAct by Friday, August 16th, to collect this 22% dividendLet's do a little math here... To double your money at a 3% rate of return, you would need around 23 years. But at a 22% rate, you could double in less than 4 years! That's why I'm so excited to tell you about my #1 ETF for monthly income. With massive payouts of 22%, this ETF outperforms the average 3% yields from Dividends Aristocrats any time of the year. And a 22% dividend isn't the only thing unique about this story...The ETF pays you every 30 days just to hold it. Get Orthofix Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for OFIX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OFIX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat are MarkeBeat Followers?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OFIX vs. The Competition Export to ExcelMetricOrthofix MedicalMedical Devices IndustryMedical SectorNASDAQ ExchangeMarket Cap$611.72M$2.54B$5.53B$8.47BDividend YieldN/A2.50%4.96%4.06%P/E Ratio-4.82228.60147.2318.90Price / Sales0.79214.071,772.4384.26Price / CashN/A16.4037.1531.47Price / Book1.013.244.954.56Net Income-$151.40M$64.43M$114.99M$225.32M7 Day Performance-2.74%2.15%9.02%4.19%1 Month Performance-0.37%0.18%15.51%7.96%1 Year Performance28.04%6.92%33.13%15.09% Orthofix Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SIBNSI-BONE4.1696 of 5 stars4.17 / 5 stars$15.73+2.4%$23.00+46.2%-29.4%$648.16M$150.71M-14.43350Positive NewsGap UpANIKAnika Therapeutics2.9771 of 5 stars2.98 / 5 stars$24.64+0.9%$30.50+23.8%+43.0%$364.67M$166.66M-4.69300Positive NewsXENTIntersect ENT0 of 5 stars0.00 / 5 stars$28.24flatN/A+0.0%$954.91M$106.75M-5.90433Analyst ForecastVAPOVapotherm0 of 5 stars0.00 / 5 stars$2.16flatN/A-29.3%$13.49M$68.67M-0.25290IARTIntegra LifeSciences4.7712 of 5 stars4.77 / 5 stars$17.47-1.0%$28.63+63.9%-55.5%$1.38B$1.57B34.943,946Gap UpATRCAtriCure3.3749 of 5 stars3.37 / 5 stars$28.21+1.8%$42.44+50.5%-33.6%$1.37B$399.24M-35.261,200Gap UpATECAlphatec4.8752 of 5 stars4.88 / 5 stars$5.59+2.0%$17.50+213.1%-53.6%$785.17M$482.26M-3.75700Short Interest ↓Gap UpSRDXSurmodics4.623 of 5 stars4.62 / 5 stars$39.36+0.9%$50.00+27.0%+15.7%$556.56M$132.58M41.43376Analyst ForecastANGOAngioDynamics4.6823 of 5 stars4.68 / 5 stars$7.64+1.7%$12.25+60.3%+3.2%$307.74M$303.91M-1.58760Short Interest ↓ARAYAccuray4.6321 of 5 stars4.63 / 5 stars$2.19+3.3%$8.25+276.7%-32.9%$217.34M$446.55M-9.951,024Gap Up Related Companies and Tools Related Companies: SI-BONE Competitors Anika Therapeutics Competitors Intersect ENT Competitors Vapotherm Competitors Integra LifeSciences Competitors AtriCure Competitors Alphatec Competitors Surmodics Competitors AngioDynamics Competitors Accuray Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:OFIX) was last updated on 9/20/2024 by MarketBeat.com Staff From Our PartnersAct by Friday, August 16th, to collect this 22% dividendLet's do a little math here... To double your money at a 3% rate of return, you would need around 23 years....Investors Alley | SponsoredWhy You Should NOT Trade This MarketYou'll be interested in our 5-Day Options Trading Challenge, starting September 23. So, what makes this dif...InvestorPlace | SponsoredNew September Stock WarningSeptember is the most volatile month of the year for stocks. And after the brutal tech selloff, one Wall St...Chaikin Analytics | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMust-Know for Trading OptionsOptions are becoming increasingly popular among investors – with demand hitting record highs for 3 years in a ...Unstoppable Prosperity | SponsoredThis Crypto Is Set to Explode in SeptemberWith thousands of cryptocurrencies out there, it's crucial to focus on the ONE that has the potential to make ...Crypto 101 Media | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | SponsoredKamala’s Dirty Election Move… RevealedAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppe...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Orthofix Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Orthofix Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.